Chronic Fatigue Syndrome (ME/CFS) Stem Cell Therapy in Istanbul, Turkey

Stem cell therapy for Chronic Fatigue Syndrome (ME/CFS) at StemCell Longevita Istanbul. MSC treatments target neuroinflammation, immune dysregulation, mitochondrial dysfunction, and gut barrier impairment — the biological roots of debilitating fatigue and post-exertional malaise.

Frequently Asked Questions About Chronic Fatigue Syndrome (ME/CFS) Stem Cell Therapy

How does stem cell therapy help Chronic Fatigue Syndrome (ME/CFS)?

MSC therapy addresses key ME/CFS mechanisms — reducing neuroinflammation, correcting immune dysregulation, improving mitochondrial energy metabolism, and repairing gut barrier dysfunction. These complementary actions target the biological roots of fatigue rather than masking symptoms.

Can stem cells improve energy levels in ME/CFS patients?

Clinical observations show that many ME/CFS patients experience meaningful improvements in energy, reduced post-exertional malaise, clearer cognitive function, and better sleep quality after MSC therapy. MSCs improve cellular energy production by supporting mitochondrial function and reducing oxidative stress.

Is stem cell therapy safe for ME/CFS patients who are sensitive to treatments?

Yes. Wharton's jelly MSCs are immunologically privileged and anti-inflammatory, making them well-tolerated even in sensitive patients. Our protocol uses a conservative approach with careful dosing and monitoring to accommodate the unique needs of ME/CFS patients.

How many stem cell therapy sessions are needed for ME/CFS?

Most ME/CFS patients receive 1–2 treatment sessions, with follow-up at 3–6 months. Patients with severe or long-standing illness may benefit from additional sessions. Our team develops an individualized plan based on symptom severity and disease duration.